Log In
BCIQ
Print this Print this
 

Remitch, nalfurafine (Winfuran) (MT-9938, TRK-820)

Also known as: formerly AC-820

  Manage Alerts
Collapse Summary General Information
Company Toray Industries Inc.
DescriptionKappa opioid receptor (KOR) agonist
Molecular Target Opioid receptor (OPR)
Mechanism of ActionKappa opioid receptor agonist
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationDermatitis
Indication DetailsImprove pruritus in patients with chronic liver disease; Treat hemodialysis-related uremic pruritus; Treat pruritus with liver cirrhosis; Treat refractory pruritus; Treat uremic pruritus; Treat uremic pruritus in dialysis patients
Regulatory Designation EU - Orphan Drug (Treat hemodialysis-related uremic pruritus)
PartnerMitsubishi Tanabe Pharma Corp.;
Sumitomo Dainippon Pharma Co. Ltd.;
Torii Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/03/2015

Undisclosed

Undisclosed

Undisclosed

10/31/2011

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today